201 related articles for article (PubMed ID: 29098552)
61. Clinical and biological significance of transcription termination factor, RNA polymerase I in human liver hepatocellular carcinoma.
Komatsu H; Iguchi T; Ueda M; Nambara S; Saito T; Hirata H; Sakimura S; Takano Y; Uchi R; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K
Oncol Rep; 2016 Apr; 35(4):2073-80. PubMed ID: 26821084
[TBL] [Abstract][Full Text] [Related]
62. Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway.
Wei S; Xiong M; Zhan DQ; Liang BY; Wang YY; Gutmann DH; Huang ZY; Chen XP
Carcinogenesis; 2012 Mar; 33(3):538-47. PubMed ID: 22226916
[TBL] [Abstract][Full Text] [Related]
63. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
[TBL] [Abstract][Full Text] [Related]
64. Identification of Gem as a new candidate prognostic marker in hepatocellular carcinoma.
Huang X; Cong X; Yang D; Ji L; Liu Y; Cui X; Cai J; He S; Zhu C; Ni R; Zhang Y
Pathol Res Pract; 2014 Nov; 210(11):719-25. PubMed ID: 25155751
[TBL] [Abstract][Full Text] [Related]
65. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1.
Kan H; Huang Y; Li X; Liu D; Chen J; Shu M
Oncotarget; 2016 Mar; 7(12):14336-49. PubMed ID: 26893361
[TBL] [Abstract][Full Text] [Related]
66. MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression.
Xiao CZ; Wei W; Guo ZX; Zhang MY; Zhang YF; Wang JH; Shi M; Wang HY; Guo RP
J Cancer Res Clin Oncol; 2017 Feb; 143(2):263-273. PubMed ID: 27704267
[TBL] [Abstract][Full Text] [Related]
67. Let-7 inhibits self-renewal of hepatocellular cancer stem-like cells through regulating the epithelial-mesenchymal transition and the Wnt signaling pathway.
Jin B; Wang W; Meng XX; Du G; Li J; Zhang SZ; Zhou BH; Fu ZH
BMC Cancer; 2016 Nov; 16(1):863. PubMed ID: 27821157
[TBL] [Abstract][Full Text] [Related]
68. The neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma.
Chen JJ; Cai N; Chen GZ; Jia CC; Qiu DB; Du C; Liu W; Yang Y; Long ZJ; Zhang Q
Oncotarget; 2017 Mar; 8(11):17593-17609. PubMed ID: 26061710
[TBL] [Abstract][Full Text] [Related]
69. TCP10L acts as a tumor suppressor by inhibiting cell proliferation in hepatocellular carcinoma.
Zuo J; Cai H; Wu Y; Ma H; Jiang W; Liu C; Han D; Ji G; Yu L
Biochem Biophys Res Commun; 2014 Mar; 446(1):61-7. PubMed ID: 24565846
[TBL] [Abstract][Full Text] [Related]
70. Overexpression of BTG2 suppresses growth, migration, and invasion of human renal carcinoma cells in vitro.
Sima J; Zhang B; Sima XY; Mao YX
Neoplasma; 2016; 63(3):385-93. PubMed ID: 26925784
[TBL] [Abstract][Full Text] [Related]
71. Expression of C19MC miRNAs in HCC associates with stem-cell features and the cancer-testis genes signature.
Augello C; Colombo F; Terrasi A; Trombetta E; Maggioni M; Porretti L; Rossi G; Guerneri S; Silipigni R; Bosari S; Vaira V
Dig Liver Dis; 2018 Jun; 50(6):583-593. PubMed ID: 29673952
[TBL] [Abstract][Full Text] [Related]
72. A multi-omic study reveals BTG2 as a reliable prognostic marker for early-stage non-small cell lung cancer.
Shen S; Zhang R; Guo Y; Loehrer E; Wei Y; Zhu Y; Yuan Q; Moran S; Fleischer T; Bjaanaes MM; Karlsson A; Planck M; Staaf J; Helland Å; Esteller M; Su L; Chen F; Christiani DC
Mol Oncol; 2018 Jun; 12(6):913-924. PubMed ID: 29656435
[TBL] [Abstract][Full Text] [Related]
73. Expression of B-cell translocation gene 2 is associated with favorable prognosis in hepatocellular carcinoma patients and sensitizes irradiation-induced hepatocellular carcinoma cell apoptosis
Chen Y; Chen C; Zhang Z; Xiao H; Mao B; Huang H; Ding C; Lei L; Zhang H; Li J; Jiang M; Wang G
Oncol Lett; 2017 Apr; 13(4):2366-2372. PubMed ID: 28454405
[TBL] [Abstract][Full Text] [Related]
74. Akt Downregulates B-Cell Translocation Gene-2 Expression Via Erk1/2 Inhibition for Proliferation of Cancer Cells.
Zubair H; Lim IK; Safi SZ; Rehman F; Imran M
Ann Clin Lab Sci; 2020 Nov; 50(6):711-716. PubMed ID: 33334784
[TBL] [Abstract][Full Text] [Related]
75. Effects of BTG2 on proliferation inhibition and anti-invasion in human lung cancer cells.
Wei S; Hao C; Li X; Zhao H; Chen J; Zhou Q
Tumour Biol; 2012 Aug; 33(4):1223-30. PubMed ID: 22392501
[TBL] [Abstract][Full Text] [Related]
76. Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis.
Ficazzola MA; Fraiman M; Gitlin J; Woo K; Melamed J; Rubin MA; Walden PD
Carcinogenesis; 2001 Aug; 22(8):1271-9. PubMed ID: 11470758
[TBL] [Abstract][Full Text] [Related]
77. Expression and significance of miRNA-21 and BTG2 in lung cancer.
Sun Q; Hang M; Guo X; Shao W; Zeng G
Tumour Biol; 2013 Dec; 34(6):4017-26. PubMed ID: 23857284
[TBL] [Abstract][Full Text] [Related]
78. Elevated BTG2 improves the radiosensitivity of non-small cell lung cancer (NSCLC) through apoptosis.
Zhu C; Zhang S; Xue A; Feng G; Fan S
Thorac Cancer; 2022 May; 13(10):1441-1448. PubMed ID: 35388633
[TBL] [Abstract][Full Text] [Related]
79. Hepatocellular Carcinoma-propagating Cells are Detectable by Side Population Analysis and Possess an Expression Profile Reflective of a Primitive Origin.
Xia H; Cao J; Li Q; Lv Y; Jia W; Ren W; Cheng Q; Song X; Xu G
Sci Rep; 2016 Oct; 6():34856. PubMed ID: 27725724
[TBL] [Abstract][Full Text] [Related]
80. [The expression of B-cell translocation gene 2 in diethylnitrosamine-induced primary hepatocellular carcinoma rat model.].
Zhang ZM; Wang G; Yang ZX; Shan JL; Chen C; Jin F; Xu W; Li Q; Luo XZ; Wang D; Li ZP
Zhonghua Gan Zang Bing Za Zhi; 2009 Feb; 17(2):107-11. PubMed ID: 19254457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
